PIK3CA and cancer: Yet, the majority (80%) of basal-like cancers have a TP53 mutation compared to 9% with a PIK3CA mutation, but only 12% of liminal A cancers have TP53 mutations compared to 45% who have PIK3CA mutations, suggesting a strong association between driver mutations and cancer subtype.